Pds biotechnology announces conference call and webcast for fourth quarter and full year 2020 financial results

Florham park, n.j., march 08, 2021 (globe newswire) -- pds biotechnology corporation (nasdaq: pdsb), a clinical-stage immunotherapy company developing novel cancer therapies and infectious disease vaccines based on the company's proprietary versamune® t-cell activating technology, today announced that the company will release financial results for the three- and twelve-month periods ended december 31, 2020 on thursday, march 18, 2021, before the market opens. following the release, management will host a conference call to review the financial results and provide a business update.
PDSB Ratings Summary
PDSB Quant Ranking